{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:12:08Z","timestamp":1793459528881,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005054","name":"Nantong University","doi-asserted-by":"publisher","award":["TDYX2021010"],"award-info":[{"award-number":["TDYX2021010"]}],"id":[{"id":"10.13039\/501100005054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31872738"],"award-info":[{"award-number":["31872738"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32470985"],"award-info":[{"award-number":["32470985"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.intimp.2025.115847","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T10:34:02Z","timestamp":1763634842000},"page":"115847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"P1","title":["PD-1+\/CXCR6+CD8+T lymphocytes promote MASLD malignant progression through inflammatory and immune dysregulation"],"prefix":"10.1016","volume":"168","author":[{"given":"Yifan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengya","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengfu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2025.115847_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.156080","article-title":"An updated overview on hepatocellular carcinoma in patients with metabolic dysfunction-associated Steatotic liver disease: trends, pathophysiology and risk-based surveillance","volume":"162","author":"Armandi","year":"2025","journal-title":"Metabolism"},{"key":"10.1016\/j.intimp.2025.115847_bb0010","doi-asserted-by":"crossref","DOI":"10.1111\/liv.70056","article-title":"A Markov model unveiling the impact of Resmetirom on the natural history of MASLD patients: a Sistematic review and Meta-analysis","volume":"45","author":"Pennisi","year":"2025","journal-title":"Liver Int."},{"issue":"5","key":"10.1016\/j.intimp.2025.115847_bb0015","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/hepr.13706","article-title":"MAFLD: renovation of clinical practice and disease awareness of fatty liver","volume":"52","author":"Kawaguchi","year":"2022","journal-title":"Hepatol. Res."},{"issue":"19","key":"10.1016\/j.intimp.2025.115847_bb0020","first-page":"2271","article-title":"From NAFLD to MAFLD: a \u201credefining\u201d moment for fatty liver disease, Chin","volume":"133","author":"Zheng","year":"2020","journal-title":"Med. J. (Engl)"},{"key":"10.1016\/j.intimp.2025.115847_bb0025","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2023.2184991","article-title":"Anti-CD122 antibody restores specific CD8(+) T cell response in nonalcoholic steatohepatitis and prevents hepatocellular carcinoma growth","volume":"12","author":"Lacotte","year":"2023","journal-title":"Oncoimmunology"},{"issue":"7854","key":"10.1016\/j.intimp.2025.115847_bb0030","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41586-021-03233-8","article-title":"Auto-aggressive CXCR6(+) CD8 T cells cause liver immune pathology in NASH","volume":"592","author":"Dudek","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2025.115847_bb0035","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jhep.2023.02.033","article-title":"Role of immune responses in the development of NAFLD-associated liver cancer and prospects for therapeutic modulation","volume":"79","author":"Yahoo","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2025.115847_bb0040","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1111\/cas.15925","article-title":"Clinicohistological and molecular features of hepatocellular carcinoma from nonalcoholic fatty liver disease","volume":"114","author":"Fujiwara","year":"2023","journal-title":"Cancer Sci."},{"key":"10.1016\/j.intimp.2025.115847_bb0045","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/cpt.1894","article-title":"Propranolol suppresses the growth of colorectal Cancer through simultaneously activating autologous CD8(+) T cells and inhibiting tumor AKT\/MAPK pathway, clin","volume":"108","author":"Liao","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.intimp.2025.115847_bb0050","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41586-022-05388-4","article-title":"Blocking PD-L1-PD-1 improves senescence surveillance and ageing phenotypes","volume":"611","author":"Wang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2025.115847_bb0055","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/s41590-023-01604-z","article-title":"CXCR6 orchestrates brain CD8(+) T cell residency and limits mouse Alzheimer's disease pathology","volume":"24","author":"Su","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2025.115847_bb0060","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jhep.2022.03.010","article-title":"Metformin treatment rescues CD8(+) T-cell response to immune checkpoint inhibitor therapy in mice with NAFLD","volume":"77","author":"Wabitsch","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2025.115847_bb0065","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/hep.28389","article-title":"NKp46(+) natural killer cells attenuate metabolism-induced hepatic fibrosis by regulating macrophage activation in mice","volume":"63","author":"Tosello-Trampont","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2025.115847_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101143","article-title":"Metabolic drivers of non-alcoholic fatty liver disease","volume":"50","author":"Bence","year":"2021","journal-title":"Mol. Metab."},{"key":"10.1016\/j.intimp.2025.115847_bb0075","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41577-020-00426-6","article-title":"How transcription factors drive choice of the T cell fate","volume":"21","author":"Hosokawa","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2025.115847_bb0080","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","article-title":"Triggering and resolution of inflammation in NASH","volume":"15","author":"Schuster","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2025.115847_bb0085","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.immuni.2016.03.016","article-title":"Memory CD8(+) T cells require increased concentrations of acetate induced by stress for optimal function","volume":"44","author":"Balmer","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2025.115847_bb0090","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3748\/wjg.v23.i2.256","article-title":"Mitochondrial carnitine palmitoyl transferase-II inactivity aggravates lipid accumulation in rat hepatocarcinogenesis","volume":"23","author":"Gu","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.intimp.2025.115847_bb0095","first-page":"748","volume":"27","year":"2019"},{"key":"10.1016\/j.intimp.2025.115847_bb0100","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","article-title":"Mechanisms of insulin action and insulin resistance","volume":"98","author":"Petersen","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.intimp.2025.115847_bb0105","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1016\/j.apsb.2022.03.012","article-title":"CXCR6-based immunotherapy in autoimmune, cancer and inflammatory infliction","volume":"12","author":"Li","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.intimp.2025.115847_bb0110","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jhep.2021.04.049","article-title":"Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis","volume":"75","author":"Pinyol","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2025.115847_bb0115","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-021-03362-0","article-title":"NASH limits anti-tumour surveillance in immuno-therapy-treated HCC","volume":"592","author":"Pfister","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2025.115847_bb0120","doi-asserted-by":"crossref","first-page":"G211","DOI":"10.1152\/ajpgi.00040.2019","article-title":"CD8(+) T cells regulate liver injury in obesity-related nonalcoholic fatty liver disease","volume":"18","author":"Breuer","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.intimp.2025.115847_bb0125","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s00535-023-02021-7","article-title":"MAFLD: an optimal framework for under- standing liver cancer phenotypes","volume":"58","author":"Crane","year":"2023","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.intimp.2025.115847_bb0130","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature24302","article-title":"Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity","volume":"551","author":"Shalapour","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2025.115847_bb0135","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/s12276-020-0480-3","article-title":"Immunological distinctions between nonalcoholic steato- hepatitis and hepatocellular carcinoma","volume":"52","author":"Koo","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.intimp.2025.115847_bb0140","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ccell.2014.09.003","article-title":"Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes","volume":"26","author":"Wolf","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2025.115847_bb0145","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/79738","article-title":"A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo","volume":"1","author":"Matloubian","year":"2000","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2025.115847_bb0150","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.immuni.2016.08.011","article-title":"Liver-resident memory CD8(+) T cells form a front-line Defense against malaria liver-stage infection","volume":"45","author":"Fernandez-Ruiz","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2025.115847_bb0155","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1126\/science.aad2035","article-title":"Hobit and Blimp1 instruct a universal trans- criptional program of tissue residency in lymphocytes","volume":"352","author":"Mackay","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.intimp.2025.115847_bb0160","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41586-019-1325-x","article-title":"TOX transcriptionally and epigenetically programs CD8(+) T cell exhaustion","volume":"571","author":"Khan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2025.115847_bb0165","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.4049\/jimmunol.1202909","article-title":"Chemokine receptor CXCR6-dependent hepatic NK T cell accumulation promotes inflammation and liver fibrosis","volume":"190","author":"Wehr","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2025.115847_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41401-020-0366-x","article-title":"Small molecule inhibitors targeting the PD-1\/PD-L1 signaling pathway","volume":"42","author":"Wu","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.intimp.2025.115847_bb0175","doi-asserted-by":"crossref","first-page":"51936","DOI":"10.18632\/oncotarget.17232","article-title":"PD1 signal transduction pathways in T cells","volume":"8","author":"Arasanz","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2025.115847_bb0180","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.intimp.2025.115847_bb0185","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.immuni.2024.01.013","article-title":"The B7:CD28 family and friends: Unraveling coinhibitory interactions","volume":"57","author":"Burke","year":"2024","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.intimp.2025.115847_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11081150","article-title":"Association between PD-1 and PD-L1 polymorphisms and the risk of Cancer: a Meta- analysis of case-control studies","volume":"11","author":"Hashemi","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.intimp.2025.115847_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13061412","article-title":"A PDCD1 role in the genetic predisposition to NAFLD-HCC?","volume":"13","author":"Eldafashi","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.intimp.2025.115847_bb0200","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1111\/liv.15586","article-title":"Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease","volume":"43","author":"Pipitone","year":"2023","journal-title":"Liver Int."},{"key":"10.1016\/j.intimp.2025.115847_bb0205","first-page":"42","article-title":"Molecular links between non-alcoholic fatty liver disease and hepatocellular carcinoma","volume":"5","author":"Raza","year":"2019","journal-title":"Hepatoma Res."},{"key":"10.1016\/j.intimp.2025.115847_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112091","article-title":"Comprehensive study of the interplay between immunological and metabolic factors in hepatic steatosis","volume":"133","author":"Banerjee","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.115847_bb0215","first-page":"2394","article-title":"Night shift-induced circadian disruption: links to initiation of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis and risk of hepatic cancer","volume":"30","author":"Singh","year":"2024","journal-title":"Hepatoma Res."},{"key":"10.1016\/j.intimp.2025.115847_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1611365","article-title":"Lymphocyte exhaustion in hepatocellular carcinoma: a dynamic evolution across disease stages","volume":"16","author":"Fuster-Anglada","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115847_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112821","article-title":"MAFLD-related hepatocellular carcinoma: exploring the potent combination of immunotherapy and molecular targeted therapy","volume":"140","author":"Guo","year":"2024","journal-title":"Int. Immunopharmacol."}],"updated-by":[{"DOI":"10.1016\/j.intimp.2025.115997","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000}}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925018351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925018351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T19:38:18Z","timestamp":1781897898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925018351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":45,"alternative-id":["S1567576925018351"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115847","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PD-1+\/CXCR6+CD8+T lymphocytes promote MASLD malignant progression through inflammatory and immune dysregulation","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115847","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115847"}}